Umbilical cord blood collection and separation for haematopoietic progenitor cell banking

Bone Marrow Transplantation
J A AdemokunA Dickinson

Abstract

Cord blood transplantation has been proven to be a suitable form of treatment for a variety of diseases in childhood and more recently in an increasing number of adult patients. Banks of cord blood cryopreserved after HLA testing are required in order to provide various HLA types for unrelated transplantation. To optimize storage space cord blood needs to be stored as a separated product. Several early methods of cord blood separation resulted in a significant loss of progenitor cells. We used a separation procedure where the donation was separated by centrifugation into a buffy coat fraction, a red cell fraction, and a plasma fraction. Twenty-five samples, (mean initial volume 81 ml) were assessed. Nucleated cells were recovered in the buffy coat fraction. Recoveries of nucleated cell count, total progenitors and CD34-positive cells in the buffy coat were 90%, 88% and 100%, respectively. The buffy fraction was tested for sterility by aerobic and anaerobic culture. Using this closed bag system, volume reduction was achieved while maintaining sterility and retaining progenitor cells in a final mean buffy coat volume of 44 ml. Red cell and plasma fractions were available for ABO grouping, virology testing and cryopreservation. Th...Continue Reading

Citations

Apr 18, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S J Fasouliotis, J G Schenker
Aug 30, 2011·Tissue Engineering. Part C, Methods·Catharina De SchauwerAnn Van Soom
Jul 14, 2001·BMJ : British Medical Journal·S J ProctorC Chapman
Aug 12, 1999·British Journal of Haematology·C DonaldsonJ Hows
Jul 3, 2009·Vox Sanguinis·C M Khodabux, A Brand
Oct 11, 2011·Transfusion·Belinda PopeRoss Grant
Dec 18, 2012·International Journal of Laboratory Hematology·T ShimaT Teshima
Jul 23, 2011·Microscopy Research and Technique·Luigi Fabrizio RodellaRita Rezzani
Aug 23, 2005·Blood Cells, Molecules & Diseases·V AdamiA Degrassi
Jun 5, 2002·Cytotherapy·M I GodinhoI L Barbosa
Jul 3, 2015·Stem Cell Research & Therapy·Santiago RouraAntoni Bayes-Genis
Jan 29, 2000·American Journal of Obstetrics and Gynecology·U ElchalalA Nagler
Apr 5, 2016·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Santiago RouraAntoni Bayes-Genis
Oct 25, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Andres CardenasMarie-France Hivert
Mar 5, 2017·International Journal of Implant Dentistry·Cagasan PirpirEmre Balaban
Feb 27, 2001·Bone Marrow Transplantation·N M-ReboredoR G Villaescusa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.